These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14586152)

  • 1. Ifosfamide in urologic cancer.
    Boccardo F; Guglielmini P
    Oncology; 2003; 65 Suppl 2():67-72. PubMed ID: 14586152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide in germ cell tumors.
    Einhorn LH
    Oncology; 2003; 65 Suppl 2():73-5. PubMed ID: 14586153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
    Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
    Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):38-41. PubMed ID: 8677447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer.
    Kaku H; Saika T; Tsushima T; Nagai A; Yokoyama T; Abarzua F; Ebara S; Manabe D; Nasu Y; Kumon H
    Acta Med Okayama; 2006 Feb; 60(1):43-9. PubMed ID: 16508688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy.
    Shinohara N; Harabayashi T; Suzuki S; Nagao K; Seki H; Murakumo M; Mitsuhashi K; Demura T; Nagamori S; Matsuyama H; Naito K; Nonomura K
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):402-7. PubMed ID: 16416335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide in the treatment of head and neck cancer.
    Airoldi M; Cortesina G; Giordano C; Pedani F; Bumma C
    Oncology; 2003; 65 Suppl 2():37-43. PubMed ID: 14586145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide in the treatment of ovarian cancer.
    Markman M
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):47-9. PubMed ID: 8677449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide in the treatment of malignant epithelial ovarian tumors.
    Lissoni AA; Fei F; Rossi R; Fruscio R; Villa A; Zani G
    Oncology; 2003; 65 Suppl 2():59-62. PubMed ID: 14586150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
    Roguin A; Ben Arush MW; Higasi A; Kuten A
    Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide in thymic neoplasms.
    Daniele O; Fornasiero A
    Oncology; 2003; 65 Suppl 2():44-5. PubMed ID: 14586146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF; Budd GT
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ifosfamide in paediatric cancer.
    Advani SH
    Aust N Z J Med; 1998 Jun; 28(3):410-3. PubMed ID: 9673760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report.
    Takahashi S; Suzuki M; Kume H; Matsumoto S; Okamoto N; Nishimatsu H; Tomita K; Kitamura T
    Jpn J Clin Oncol; 2005 Feb; 35(2):79-83. PubMed ID: 15709091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide in the treatment of bladder cancer.
    Roth BJ
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):50-5. PubMed ID: 8677450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
    Markman M; Kennedy A; Sutton G; Hurteau J; Webster K; Peterson G; Kulp B; Belinson J
    Gynecol Oncol; 1998 Aug; 70(2):272-4. PubMed ID: 9740704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide in the treatment of lymphoma.
    Coiffier B
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):2-7. PubMed ID: 8711498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of advanced urological tumors].
    Krege S
    Onkologie; 2003 Oct; 26 Suppl 4():13-7. PubMed ID: 14605451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.